December 5, 2024 12:26 PM
Long-term benefit from anti-hormonal treatment is influenced by menopausal status: Study
Women with estrogen-sensitive breast cancer now receive anti-hormonal therapy. Researchers have discovered that postmenopausal women with low-risk tumors experience long-term benefits for at least 20 years, whereas younger women with similar tumor ch...
